BreStem Therapeutics, Inc. — Form D/A
BreStem Therapeutics, Inc. of RALEIGH, NC, a company, filed a Form D amendment with the SEC on 2021-11-24. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-11-24
- Form: D/A
- Accession: 0001723963-21-000005
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 3
- Date of first sale: 2021-06-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405341
Issuer
- Name: BreStem Therapeutics, Inc.
- CIK: 0001723963
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2017
- Address: 1001 WILLIAM MOORE DRIVE, RALEIGH, NC, 27606
- Phone: 919-513-6157
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Ke Cheng | Director | RALEIGH, NC |
| Weigang Wang | Director | RALEIGH, NC |
| Weili Zhou | Director | RALEIGH, NC |
| Ke Cheng | Executive Officer | RALEIGH, NC |
| Dongmei Zhu | Executive Officer | Raleigh, NC |
Other filings by this issuer (2)
More